The activity of IDO was inversely related to IL-6 levels in COVID-19 patients, but the acylcarnitines, kynurenine, and methionine sulfoxide metabolites were positively correlated with IL-6 levels [168]. This evidence concerns the gene IL6 and COVID-19.